A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints

DOI10.1002/BIMJ.201800313zbMath1429.62574OpenAlexW2959089420WikidataQ91824880 ScholiaQ91824880MaRDI QIDQ5213412

Pavel Mozgunov, Thomas Jaki

Publication date: 3 February 2020

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.201800313

zbMATH Keywords

phase I/II clinical trialcontinuous endpointcombination trialnonmonotonic efficacy

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (1)

Unnamed Item

This page was built for publication: A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints